Tenax Therapeutics Meets Nasdaq’s Float Requirement Compliance
Company Announcements

Tenax Therapeutics Meets Nasdaq’s Float Requirement Compliance

Tenax Therapeutics (TENX) has released an update.

Tenax Therapeutics, Inc. has successfully regained compliance with Nasdaq’s Minimum Float Requirement by achieving over 500,000 publicly held shares, a milestone that rectifies their previous non-compliance issue from January 11, 2024. This achievement ensures the company’s continued inclusion on the Nasdaq Capital Market and marks the closure of the matter.

For further insights into TENX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskTenax Therapeutics Expands Stock Incentive Plan
TheFlyTenax Therapeutics initiated with an Outperform at Leerink
TheFlyTenax Therapeutics initiated with a Buy at Guggenheim
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App